Labshake search
Citations for Tocris :
301 - 350 of 1128 citations for PI 3065 CAS 955977 50 1 98% since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... Matured iMGLs at density of 15 000 cells/well on 96-well plates were treated with 0.3-50 µM Yoda1 (Tocris) or equal volume of DMSO ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 nM gastrin, 50 ng/ml recombinant human EGF (R&D, 236-EG) and 500 nM A83-01 (Tocris). Organoids were passaged every 4 days by physical dissociation using fire-polished Pasteur pipettes.
-
bioRxiv - Bioengineering 2024Quote: ... cells were either directly imaged or washed 1x and incubated for 5 min with Hoechst 33342 (Tocris, 5117/50) to a final concentration 1 ng/µL prior to imaging ...
-
bioRxiv - Immunology 2024Quote: ... we administered 3 doses (100 uL) of either vehicle control or 50 ug of the CCR3 antagonist (SB328437, Tocris) via intraperitoneal injection before TAC and during the first week of recovery ...
-
bioRxiv - Molecular Biology 2021Quote: ... 1 µM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Developmental Biology 2023Quote: ... 1 μM DMH-1 (Tocris) and 3 μM CHIR99021 (Tocris) ...
-
bioRxiv - Neuroscience 2020Quote: Designer receptor-ligand clozapine-N-oxide (CNO, Tocris Bioscience; 4936, CAS No: 34233-69-7) was dissolved in 0.9 % saline solution at a concentration of 0.1 mg/ml and administered i.p ...
-
bioRxiv - Neuroscience 2023Quote: ... aCSF containing 10 µm BAPTA-AM (CAS: 126150-97-8, Tocris Biosciences, Minneapolis, MN, USA) was perfused onto the slice at a rate of 2 mL per minute for at least 30 minutes after the baseline recordings were taken.
-
bioRxiv - Neuroscience 2021Quote: ... and GABA-A receptor blockers (10 μM GYKI 52466 cat #1454, 10 μM CPP cat #0247, 50 μM picrotoxin cat #1128, final concentrations, all from Tocris), with a bath perfusion rate of ∼2 ml/min ...
-
bioRxiv - Neuroscience 2020Quote: ... and miniature IPSCs (mIPSCs) were recorded in presence of APV and NBQX (Tocris; 50 μM and 10 μM APV respectively) to block AMPAR and NMDAR currents ...
-
bioRxiv - Neuroscience 2021Quote: ... and GluN2BGC−/− mice (P40 – P60) were stereotactically injected with 50 nl of 20 mM solution of kainic acid (Tocris / Biotechne) in 0.9 % NaCl to the left CA1 area of the dorsal hippocampus (AP −1.8 mm ...
-
bioRxiv - Cell Biology 2021Quote: ... media was removed and cells were washed twice with 100 μL PBS 1X/well and then immediately stained with 50 μmol/L MitoPY1 probe (4428, Tocris) for 30 min at 37°C in PBS 1X ...
-
bioRxiv - Neuroscience 2022Quote: ... females with regular estrous cycles underwent intrahippocampal injection of either KA (Tocris; 50 nl of 20 mM, n = 9 mice) or control sterile 0.9% saline (n = 6 mice ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 μM NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline) and 50 μM AP-5 (Tocris Bioscience, UK) were applied in the bath to block excitatory synaptic responses.
-
bioRxiv - Physiology 2022Quote: ... sperm were incubated with either dimethyl sulfoxide (DMSO; 0.5% v/v) as a carrier control or the sAC inhibitor KH7 (50 μM; Tocris Bioscience) for 30 minutes ...
-
bioRxiv - Neuroscience 2022Quote: ... and finally the cells got depolarized to +40 mV to measure NMDA-mediated currents which were blocked by the selective NMDA antagonist AP-V (50 uM; Tocris). The synaptic properties of GPi Vglut2+/Vgat+ projections onto GPe neurons were probed using multiple light pulse train protocols with 3 ms blue light pulses with ∼2.5 mW light power from a pE-4000 (CoolLED ...
-
bioRxiv - Neuroscience 2023Quote: ... Neuronal activity was manipulated either with field stimulation (100mA,10 Hz,600 AP) or 6 hours of 50 µM picrotoxin (PTX, Tocris) treatment 65 ...
-
bioRxiv - Biochemistry 2023Quote: ... Washed membranes were incubated in the hypotonic buffer in the presence of 2 mg/ml iodoacetamide and 50 μm SSR149415 (Tocris) for 20 min ...
-
bioRxiv - Immunology 2023Quote: ... the mice received subcutaneous injections of either the CCR1-specific antagonist BX471 (50 mg/kg body weight; Tocris, Bristol, UK) or vehicle (40% cyclodextrin in saline ...
-
bioRxiv - Developmental Biology 2021Quote: ... and 1 μM IDE-1 and 1 μM XAV939 (both Tocris). 48 hours after the onset of differentiation ...
-
bioRxiv - Developmental Biology 2022Quote: ... 1 μM endo-IWR-1 (Tocris), and 10 μM SB431542 (Stemgent).
-
bioRxiv - Developmental Biology 2023Quote: ... and 1 μM DMH-1 (Tocris) and mixed with 90 μl Growth Factor Reduced Matrigel (Corning) ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 1 μM DMH-1 (Tocris) on 6-well ECM collagen-I-coated peptide plates (Corning ...
-
bioRxiv - Neuroscience 2021Quote: ... NMDA receptor (R) dependency was tested by application of an NMDAR antagonist (APV 50 µM, DL-2-Amino-5-phosphonopentanoic acid, Tocris, Germany) in the bath solution ...
-
bioRxiv - Cell Biology 2021Quote: COS-7 cells were transfected with plasmids for expression of KIF5C(1-560)-WT-Halo-Flag or KIF5C(1-560)-Δ6-Halo-Flag and the protein was fluorescently labelled by the inclusion of 50 nM JF552 Halo ligand (Tocris Bioscience) in the growth medium ...
-
bioRxiv - Cell Biology 2021Quote: ... AMPAR- and NMDAR-EPSC postsynaptic currents were pharmacologically isolated by adding the GABAA receptor blocker picrotoxin (50 μM) (Tocris Cat#1128) to the extracellular bath solution ...
-
bioRxiv - Neuroscience 2022Quote: ... containing 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5) (both from Tocris, Bristol, UK) to block recurrent glutamatergic signaling.
-
bioRxiv - Neuroscience 2023Quote: ... Experiments were performed at room temperature in oxygenated ACSF containing 50 μM of the GABAA receptor antagonist picrotoxin (Tocris, Ellisville, MO). Recordings from synapses that were silent (failure of transmission at -70 mV ...
-
bioRxiv - Neuroscience 2023Quote: ... Firing rates of individual channels were compared before and after treatment with potassium channel blocker 4-AP (50 μM; Tocris, 0940), sodium channel blocker TTX (1 μM ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Cancer Biology 2021Quote: ... Torin1 (1 μM, Tocris, 10-1-4247), and AICAR (2 mM ...
-
bioRxiv - Developmental Biology 2022Quote: ... and endothelin 1 (ET-1) from Tocris Bioscience (Bristol ...
-
bioRxiv - Developmental Biology 2024Quote: ... Sphingosine-1-phosphate (S1P) (1 µM, TOCRIS) and 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI ...
-
bioRxiv - Neuroscience 2022Quote: ... in the presence of 50 µM of the broad spectrum glutamate transporter blocker DL-threo-beta-benzyloxyaspartate (DL-TBOA; Tocris Bioscience; [82]), to determine the non-specific binding to gliosome membranes ...
-
bioRxiv - Neuroscience 2021Quote: ... The bath solution usually contained 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 µM) and D- aminophosphonovaleric acid (D-APV, 50 µM) to block ionotropic glutamate receptors (Tocris, Abingdon, United Kingdom). Patch electrodes had resistances of 4-6 MΩ when filled with KMeSO4- or CMeSO4-based internal solution (same as used in vivo) ...
-
bioRxiv - Neuroscience 2020Quote: ... containing 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5) to block glutamatergic signaling (both from Tocris, Bristol, UK). Experiments involving tetrodotoxin (TTX ...
-
bioRxiv - Cancer Biology 2022Quote: The following chemical inhibitors targeting different effectors of the TGF-β-pathway were used: TGFbR-inhibitor A83-01 [50 nM] (Tocris Bioscience), p38-inhibitors SB202190 [10 μM] (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2022Quote: ... these experiments were performed in the presence of AMPA and NMDA receptor blockade (10 µM NBQX and 50 µM D-AP5 respectively; Tocris, Bristol, UK). To isolate excitatory currents ...
-
bioRxiv - Neuroscience 2023Quote: ... and cells were centrifuged at 200 rcf for 5 min and resuspended in N2B27 with the same supplements as on day 0 except for the removal of Y27632 and addition of all-trans retinoic acid (100 nM; Tocris, 0695/50) and SAG (500 nM ...
-
bioRxiv - Genomics 2021Quote: ... and 1 μM tetrodotoxin (TTX; Tocris #1078/1). KCl (55mM ...
-
bioRxiv - Neuroscience 2021Quote: ... namely the mitogen activated protein kinase kinase (MAPKK) inhibitor U0126 (50 μM) and the CaM kinase II (CaMKII) inhibitor KN-62 (10 μM) (Tocris Bioscience, United Kingdom). The inhibitors were added to the cultures thirty minutes prior to DOI treatment ...
-
bioRxiv - Cell Biology 2022Quote: ... MLSA1 (Tocris, 4746, incubation 1 μM for 1 h). For all experiments in microfluidic chips involving drugs ...
-
bioRxiv - Neuroscience 2020Quote: ... rabbit anti-GLT-1 (Tocris, #2063, dilution 1:2000). Secondary antibodies against mouse ...
-
bioRxiv - Cell Biology 2024Quote: ... and Torin-1 (1 mM final, Tocris/Biotechne #4247), with DMSO as vehicle controls.
-
bioRxiv - Neuroscience 2023Quote: ... Glutamate uncaging was achieved by applying a single 150-ms pulse of UV light (356 nm) through the microscope objective every 20 s to a bath containing MNI-glutamate (50 µM, Tocris, Bioscience, Bristol, United Kingdom). NMDA components were measured as currents 20 ms after the peak ...
-
bioRxiv - Neuroscience 2021Quote: ... and nor-Binaltorphimine dihydrochloride (norBNI, KOR antagonist, 10 mg/kg, i.p.) (CAS# 113158-34-2) were obtained from Tocris and dissolved in 0.9% sterile saline ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 DAMGO (Tocris), 10 Bombesin (Tocris) ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 0.3 or 1 mg/kg of the mGlu2/3 receptor agonist LY379268 (Cat No.: 2453, Batch No.: 9B/232416, CAS No.: 191471-52-0, Tocris Bioscience ...